Risk-benefit trade-offs in revascularisation choices. - Wikidata - awgldk - TriplyDB

Risk-benefit trade-offs in revascularisation choices.

Risk-benefit trade-offs in revascularisation choices.

http://www.wikidata.org/entity/Q34700769

about

Revascularization in multivessel CAD: a functional approach.TREATMENT AFTER ACUTE CORONARY SYNDROME: ANALYSIS OF PATIENT'S PRIORITIES WITH ANALYTIC HIERARCHY PROCESS.Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.Global Risk Score and Clinical SYNTAX Score as Predictors of Clinical Outcomes of Patients Undergoing Unprotected Left Main Percutaneous Catheter Intervention.Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions.

P2860

Q37980017-81590ADD-6135-4861-B98F-31FA782BAFB1 Q38810315-925DE9B7-518D-4DFF-B254-4FEDECA771BE Q41757905-4ADA1B98-E1B1-49D0-AE38-75424D3C8D63 Q47385190-C902372D-4A7B-44B0-B8C7-7DCA7DD8D0B9 Q48002756-4B7C1B63-233F-4690-91F7-299F4062333E

P2860

Risk-benefit trade-offs in revascularisation choices.

http://www.wikidata.org/entity/Q34700769

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Risk-benefit trade-offs in revascularisation choices.

@ast

Risk-benefit trade-offs in revascularisation choices.

@en

Risk-benefit trade-offs in revascularisation choices.

@nl

type

label

Risk-benefit trade-offs in revascularisation choices.

@ast

Risk-benefit trade-offs in revascularisation choices.

@en

Risk-benefit trade-offs in revascularisation choices.

@nl

prefLabel

Risk-benefit trade-offs in revascularisation choices.

@ast

Risk-benefit trade-offs in revascularisation choices.

@en

Risk-benefit trade-offs in revascularisation choices.

@nl

P1433

Q34700769-71A7B6B3-534C-412E-8D14-50629A4F4D01

P1476

Q34700769-ECF87F68-5B74-4A74-AFEF-9F78D4B06EE9

P2093

Q34700769-024FA23F-F2F5-47C8-B95A-48A52BDAD5DF

Q34700769-0AB513C0-6D7A-4001-A7C8-9C8C69AA909A

Q34700769-4BE4336B-F137-4E75-9BE3-C9F183E74025

Q34700769-63E311FD-9FA9-4EA4-A35E-A449C6D9ADB2

Q34700769-EDEAC04B-E233-4AAA-9117-0A57E3FC24B0

P2860

Q34700769-11DCE736-5AF8-48B6-8F19-FFFF4A686158

Q34700769-1F662A39-EF8F-42D6-BBB0-4DDF930B47F4

Q34700769-4007CD3A-56B8-48EC-8D51-575A2E977789

Q34700769-4398B21E-C4DD-405D-AA1A-4257E6647C93

Q34700769-47326B01-7AEA-47B3-895C-E907E19765B6

Q34700769-50FA09F8-6EF9-4C5A-85A0-1E55659F707F

Q34700769-5696D652-DC01-41FD-8BBA-1546C92DA348

Q34700769-6A8D3A6A-6F7D-4BFC-AE64-67B22F7348B3

Q34700769-705A5AC0-C74E-4093-ADE6-E51E67DA29ED

Q34700769-7659D2F7-176B-4964-833B-38A0DEE552EC

P304

Q34700769-DFD13213-E8DB-4308-94BC-C79D674E7DB2

P31

Q34700769-D7C4B91B-43C3-4EDF-B84A-EF6449AD549E

P356

Q34700769-9557141D-FFCD-42C1-B9BF-DFE290D113F9

P433

Q34700769-B394F02A-F4AB-4032-9C8D-7E91BFFE85A6

P478

Q34700769-4E37CC34-BBB8-4057-882F-F55B80FEA9C5

P50

Q34700769-54E76D66-B5E0-474F-A4BF-1F58310E6B0A

P577

Q34700769-F883EA51-F193-4A2F-B41E-2E91FAF87006

P5875

Q34700769-9D4C3190-0568-47D8-9EEC-DACBB1D299E0

P698

Q34700769-8FB6B37E-4B2C-432C-9177-4FB429C97E4E

P921

Q34700769-B859AADC-D47A-4B3A-B905-13B0DECBB0CA

P932

Q34700769-CAA89D62-50A1-4326-93B5-4D27EEC127D2

P356

P1433

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

P1476

Risk-benefit trade-offs in revascularisation choices.

@en

P2093

Brett C Sheridan

http://www.w3.org/2001/XMLSchema#string

Jennifer L Lund

http://www.w3.org/2001/XMLSchema#string

Jerome J Federspiel

http://www.w3.org/2001/XMLSchema#string

Ron T van Domburg

http://www.w3.org/2001/XMLSchema#string

Sally C Stearns

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients

Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease

Percutaneous coronary intervention: recommendations for good practice and training.

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS tr

Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial.

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Coronary revascularization in the community. A population-based study, 1990 to 2004.

P304

936-941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4244/EIJV6I8A163

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Patrick W Serruys

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49844643

http://www.w3.org/2001/XMLSchema#string

P698

21330240

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

P932

3061312

http://www.w3.org/2001/XMLSchema#string